/ About / By The Numbers

By The Numbers

A record setting year of innovation — In FY19 we saw researchers from across campus working with the OLV team to make records for the number of inventions, agreements, and start-ups.

Duke Start-ups: Impact in North Carolina and Beyond

By the numbers
142
Companies formed
$5.2B
Raised in private and public financing
9
IPOs

Annual Reports

Duke is an innovative place to be right now–we’re turning our world class research into viable commercial products.

See our 2019 Annual Report

See our 2018 Annual Report

See our 2017 Annual Report

2019 Impact

354

Disclosures

120

Agreements

90

Issued Patents

$58M

In Revenue

Duke Startups

Duke Total Invention Disclosure & Agreements

Recent Success Stories

Tellus Therapeutics Wins Early Stage Company Shootout,
Tellus Therapeutics

DECEMBER 4, 2018 An A-List Group Of Investors And Companies Attended The 20th Anniversary Southeast BIO Investor & Partnering Forum (SEBIO) On November 13-14th At The Loews…

Read More
Deep Blue receives FDA clearance for hernia mesh product, Deep Blue Medical Advances, Inc.

DURHAM – Medtech startup Deep Blue Medical Advances can now begin selling a novel hernia mesh product with enhanced anchoring strength following receipt of FDA…

READ MORE >
New space for biomedical engineering research , Lumedica

[Originally posted by Duke Magazine— June 12, 2018] When Adam Wax A.M. ’96, Ph.D. ’99, president and chief scientist of Lumedica, has a question about the…

READ MORE >
kēlaHealth Among 6 to Win NC IDEA grant, kēlaHealth

November 20th, 2017 Today NC IDEA, a private foundation supporting entrepreneurial innovation North Carolina, announced the recipients of the Fall 2017 NC IDEA Seed Grant…

READ MORE >
Infinia ML Wins “Best Machine Learning Company” Award , Infinia ML, Inc.

DURHAM, N.C., June 26, 2018 /PRNewswire/ -- Infinia ML, an advanced machine learning company that delivers transformative automation solutions and predictive analytics to enterprise businesses, today announced…

READ MORE >
Grid Therapeutics Signs Exclusive License Agreement to Develop a Novel Immuno-Oncology Antibody, Grid Therapeutics

Grid Therapeutics, LLC, an oncology-focused biotechnology company announced the execution of an exclusive license agreement with Duke University to develop the first human derived antibody…

READ MORE >
Realtime Robotics Secures $2M in Seed Funding, Realtime Robotics

[Press Release from Realtime Robotics, July 3, 2018] Realtime Robotics, Inc Awarded Competitive Grant from the National Science Foundation Realtime Robotics has been awarded a…

READ MORE >
IonQ Raises $20M Series B Round, IonQ

COLLEGE PARK, Md., July 26, 2017 /PRNewswire/ -- IonQ, an early-stage company developing quantum computing for commercial applications, today announced completion of a $20 million series B round led by…

READ MORE >
CaregiverAsia and Holmusk partner to provide customized home care solutions, Holmusk USA, Inc

Caregiver Asia Pte Ltd, an online aggregator of on-demand health and caregiving services, and Holmusk, a digital health and data science company, has partnered to…

READ MORE >
Duke spinout developing 'revolutionary' diagnostics device, SenGenix, Inc

[Originally published July 21, 2014. By Jason deBruyn, Triangle Business Journal] SenGenix, a small company born in a Duke University lab, is developing a new…

READ MORE >
View All